These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 3595732)
1. The influence of parathyroid hormone and its fragments on results from midregion and C-terminal specific radioimmunoassays. Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M Exp Clin Endocrinol; 1987 Mar; 89(1):61-9. PubMed ID: 3595732 [TBL] [Abstract][Full Text] [Related]
2. Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands. Flueck JA; Di Bella FP; Edis AJ; Kehrwald JM; Arnaud CD J Clin Invest; 1977 Dec; 60(6):1367-75. PubMed ID: 915003 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure. Gautvik KM; Gautvik VT; Halvorsen JF Scand J Clin Lab Invest; 1983 Nov; 43(7):553-64. PubMed ID: 6658372 [TBL] [Abstract][Full Text] [Related]
4. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients. Hackeng WH; Lips P; Netelenbos JC; Lips CJ J Clin Endocrinol Metab; 1986 Aug; 63(2):447-53. PubMed ID: 3088025 [TBL] [Abstract][Full Text] [Related]
5. The effect of high parathyroid hormone concentration on calcitonin in patients with primary hyperparathyroidism. Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M Exp Clin Endocrinol; 1987 Dec; 90(3):324-30. PubMed ID: 3450531 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of hypocalcemia with a highly sensitive, homologous radioimmunoassay for the midregion of parathyroid hormone. Mallette LE; Wilson DP; Kirkland JL Pediatrics; 1983 Jan; 71(1):64-9. PubMed ID: 6848981 [TBL] [Abstract][Full Text] [Related]
7. Estimation of biologically active intact parathyroid hormone in normal and hyperparathyroid sera by sequential N-terminal immunoextraction and midregion radioimmunoassay. Lindall AW; Elting J; Ells J; Roos BA J Clin Endocrinol Metab; 1983 Nov; 57(5):1007-14. PubMed ID: 6311857 [TBL] [Abstract][Full Text] [Related]
8. Comparison of C-terminal and N-terminal PTH in secondary hyperparathyroidism in renal failure. Hortling L; Puutula-Räsänen L; Fyhrquist F Scand J Urol Nephrol Suppl; 1985; 90():51-4. PubMed ID: 3868028 [TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay for human parathyroid hormone for differentiation between patients with hypoparathyroidism, hyperparathyroidism and normals. Streibl W; Minne H; Raue F; Ziegler R Horm Metab Res; 1979 May; 11(5):375-6. PubMed ID: 478433 [TBL] [Abstract][Full Text] [Related]
10. Measurement of parathyroid hormone. Endres DB; Villanueva R; Sharp CF; Singer FR Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765 [TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone: radioimmunoassay and clinical interpretation. Hawker CD Ann Clin Lab Sci; 1975; 5(5):383-98. PubMed ID: 1180481 [TBL] [Abstract][Full Text] [Related]
12. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas. Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640 [TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
14. Immunological evidences for the presence of small late carboxylterminal fragment(s) of human parathyroid hormone (PTH) in circulation in man. D'Amour P; Labelle F; Wolde-Giorghis R; Hamel L J Immunoassay; 1989; 10(2-3):191-205. PubMed ID: 2745718 [TBL] [Abstract][Full Text] [Related]
15. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay. Blind E; Schmidt-Gayk H; Scharla S; Flentje D; Fischer S; Göhring U; Hitzler W J Clin Endocrinol Metab; 1988 Aug; 67(2):353-60. PubMed ID: 3292561 [TBL] [Abstract][Full Text] [Related]
16. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies. Gautvik KM; Gordeladze JO; Moxheim E; Gautvik VT Eur Surg Res; 1984; 16 Suppl 2():41-54. PubMed ID: 6723731 [TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide. Marx SJ; Sharp ME; Krudy A; Rosenblatt M; Mallette LE J Clin Endocrinol Metab; 1981 Jul; 53(1):76-84. PubMed ID: 7240381 [TBL] [Abstract][Full Text] [Related]
18. Immunoassays for the detection of parathyroid hormone. Jüppner H; Potts JT J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782 [TBL] [Abstract][Full Text] [Related]
19. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism. Nussbaum SR; Potts JT J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383 [TBL] [Abstract][Full Text] [Related]
20. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery. Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]